{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:28:06Z","timestamp":1773883686255,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,26]],"date-time":"2026-11-26T00:00:00Z","timestamp":1795651200000},"content-version":"am","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AGR01046543"],"award-info":[{"award-number":["AGR01046543"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AGR01054771"],"award-info":[{"award-number":["AGR01054771"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AGR01050515"],"award-info":[{"award-number":["AGR01050515"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AGR01071522"],"award-info":[{"award-number":["AGR01071522"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jagp.2025.09.020","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:57:02Z","timestamp":1758949022000},"page":"70-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relationship Between SSRI Exposure During Later Life and Clinical and Neuropathological Correlates of Dementia"],"prefix":"10.1016","volume":"34","author":[{"given":"Jacob S.","family":"Shaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.C.","family":"Bray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney K.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantine G.","family":"Lyketsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew E.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jagp.2025.09.020_bib0001","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for alzheimer disease: systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"10.1016\/j.jagp.2025.09.020_bib0002","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1192\/bjp.bp.112.118307","article-title":"Late-life depression and risk of vascular dementia and alzheimer's disease: systematic review and meta-analysis of community-based cohort studies","volume":"202","author":"Diniz","year":"2013","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.jagp.2025.09.020_bib0003","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1212\/WNL.0b013e3181e62124","article-title":"Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment","volume":"75","author":"Dotson","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2025.09.020_bib0004","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jad.2022.01.083","article-title":"Depression in adulthood and risk of dementia later in life: a danish register-based cohort study of 595,828 men","volume":"302","author":"Larsen","year":"2022","journal-title":"J Affect Disord"},{"issue":"7","key":"10.1016\/j.jagp.2025.09.020_bib0005","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/jamapsychiatry.2017.0660","article-title":"Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study","volume":"74","author":"Singh-Manoux","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.jagp.2025.09.020_bib0006","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archgenpsychiatry.2011.1481","article-title":"Midlife vs late-life depressive symptoms and risk of dementia: differential effects for alzheimer disease and vascular dementia","volume":"69","author":"Barnes","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"10.1016\/j.jagp.2025.09.020_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034924","article-title":"Association between dementia and depression: a retrospective study using the korean national health insurance service-national sample cohort database","volume":"10","author":"Yu","year":"2020","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.jagp.2025.09.020_bib0008","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S2215-0366(16)00097-3","article-title":"10-year trajectories of depressive symptoms and risk of dementia: a population-based study","volume":"3","author":"Mirza","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jagp.2025.09.020_bib0009","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.dadm.2019.02.006","article-title":"Time course of neuropsychiatric symptoms and cognitive diagnosis in national alzheimer's coordinating centers volunteers","volume":"11","author":"Wise","year":"2019","journal-title":"Alzheimers Dement (Amst)"},{"issue":"6","key":"10.1016\/j.jagp.2025.09.020_bib0010","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jagp.2024.01.015","article-title":"The relationship between first presenting neuropsychiatric symptoms in older adults and autopsy-confirmed memory disorders","volume":"32","author":"Shaw","year":"2024","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.jagp.2025.09.020_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-020-0839-1","article-title":"Depression: an underrecognized target for prevention of dementia in alzheimer\u2019s disease","volume":"10","author":"Dafsari","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"4","key":"10.1016\/j.jagp.2025.09.020_bib0012","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000121334","article-title":"Is antidepressant treatment associated with reduced cognitive decline in alzheimer's disease?","volume":"25","author":"Mossello","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"10.1016\/j.jagp.2025.09.020_bib0013","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/JCP.0b013e31802e0002","article-title":"Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial","volume":"27","author":"Mowla","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jagp.2025.09.020_bib0014","first-page":"411","article-title":"Effects of fluoxetine on brain-derived neurotrophic factor serum concentration and cognition in patients with vascular dementia","volume":"9","author":"Liu","year":"2014","journal-title":"Clin Interv Aging"},{"issue":"4\u20135","key":"10.1016\/j.jagp.2025.09.020_bib0015","first-page":"131","article-title":"Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in alzheimer patients","volume":"47","author":"Mokhber","year":"2014","journal-title":"Pharmacopsychiatry"},{"issue":"7","key":"10.1016\/j.jagp.2025.09.020_bib0016","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.60.7.737","article-title":"Treating depression in alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS","volume":"60","author":"Lyketsos","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.jagp.2025.09.020_bib0017","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/appi.ajp.2017.17040404","article-title":"Impact of SSRI therapy on risk of conversion from mild cognitive impairment to alzheimer's dementia in individuals with previous depression","volume":"175","author":"Bartels","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.jagp.2025.09.020_bib0018","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12916-025-03851-3","article-title":"Antidepressant use and cognitive decline in patients with dementia: a national cohort study","volume":"23","author":"Mo","year":"2025","journal-title":"BMC Med"},{"issue":"19","key":"10.1016\/j.jagp.2025.09.020_bib0019","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.3390\/jcm12196342","article-title":"Association between antidepressants and dementia risk in older adults with depression: a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jagp.2025.09.020_bib0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/WAD.0000000000000103","article-title":"Antidepressant use in the elderly is associated with an increased risk of dementia","volume":"30","author":"Wang","year":"2016","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"11","key":"10.1016\/j.jagp.2025.09.020_bib0021","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jagp.2019.05.019","article-title":"Exposure to antidepressant medication and the risk of incident dementia","volume":"27","author":"Kodesh","year":"2019","journal-title":"Am J Geriatr Psychiatr"},{"issue":"9","key":"10.1016\/j.jagp.2025.09.020_bib0022","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jagp.2024.03.004","article-title":"Depressive symptoms and plasma markers of alzheimer's disease and neurodegeneration: a coordinated meta-analysis of 8 cohort studies","volume":"32","author":"Twait","year":"2024","journal-title":"Am J Geriatr Psychiatr"},{"key":"10.1016\/j.jagp.2025.09.020_bib0023","article-title":"Antidepressants as a potential candidate to reduce microglia activation in neurodegenerative diseases. A systematic review and meta-analysis of preclinical studies","volume":"11","author":"Nicolai","year":"2023","journal-title":"J Affect Disord Rep"},{"issue":"11","key":"10.1016\/j.jagp.2025.09.020_bib0024","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2174\/1567205014666170203141717","article-title":"Neuroinflammation and alzheimer's disease: implications for microglial activation","volume":"14","author":"Regen","year":"2017","journal-title":"Curr Alzheimer Res"},{"issue":"8","key":"10.1016\/j.jagp.2025.09.020_bib0025","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1093\/brain\/awad078","article-title":"Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia","volume":"146","author":"Malpetti","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2025.09.020_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1039780","article-title":"The role of microglial autophagy in parkinson\u2019s disease","volume":"14","author":"Zhu","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"36","key":"10.1016\/j.jagp.2025.09.020_bib0027","doi-asserted-by":"crossref","first-page":"14968","DOI":"10.1073\/pnas.1107411108","article-title":"Serotonin signaling is associated with lower amyloid-\u03b2 levels and plaques in transgenic mice and humans","volume":"108","author":"Cirrito","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"10.1016\/j.jagp.2025.09.020_bib0028","doi-asserted-by":"crossref","first-page":"e2658","DOI":"10.1212\/WNL.0000000000010725","article-title":"Effect of escitalopram dose and treatment duration on CSF a\u03b2 levels in healthy older adults","volume":"95","author":"Sheline","year":"2020","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jagp.2025.09.020_bib0029","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3233\/JAD-170387","article-title":"Serotonin selective reuptake inhibitor treatment improves cognition and grey matter atrophy but not amyloid burden during two-year follow-up in mild cognitive impairment and alzheimer's disease patients with depressive symptoms","volume":"65","author":"Brendel","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"10.1016\/j.jagp.2025.09.020_bib0030","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/mp.2013.20","article-title":"The vascular depression hypothesis: mechanisms linking vascular disease with depression","volume":"18","author":"Taylor","year":"2013","journal-title":"Mol Psychiatry"},{"issue":"6","key":"10.1016\/j.jagp.2025.09.020_bib0031","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13061","article-title":"Pathological changes within the cerebral vasculature in alzheimer\u2019s disease: new perspectives","volume":"32","author":"Fisher","year":"2022","journal-title":"Brain Pathol"},{"issue":"1","key":"10.1016\/j.jagp.2025.09.020_bib0032","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00415-012-6616-1","article-title":"Antidepressant use is related to larger white matter lesion volume in patients with symptomatic atherosclerotic disease: the SMART-MR study","volume":"260","author":"Grool","year":"2013","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.jagp.2025.09.020_bib0033","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2012-112009","article-title":"Depressive symptoms, antidepressant use, and brain volumes on MRI in a population-based cohort of old persons without dementia","volume":"30","author":"Geerlings","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.jagp.2025.09.020_bib0034","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","article-title":"Accuracy of the clinical diagnosis of alzheimer disease at national institute on aging alzheimer's disease centers, 2005\u20132010","volume":"71","author":"Beach","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"10.1016\/j.jagp.2025.09.020_bib0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1590\/S1980-57642011DN05040003","article-title":"Vascular dementia: diagnostic criteria and supplementary exams.Recommendations of the scientific department of cognitive neurology and aging ofthe brazilian academy of neurology. Part I","volume":"5","author":"Engelhardt","year":"2011","journal-title":"Dement Neuropsychol"},{"key":"10.1016\/j.jagp.2025.09.020_bib0036","first-page":"23","article-title":"Research criteria for subcortical vascular dementia in clinical trials","volume":"59","author":"Erkinjuntti","year":"2000","journal-title":"J Neural Transm Suppl"},{"issue":"4","key":"10.1016\/j.jagp.2025.09.020_bib0037","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.wad.0000213865.09806.92","article-title":"The uniform data set (UDS): clinical and cognitive variables and descriptive data from alzheimer disease centers","volume":"20","author":"Morris","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"9","key":"10.1016\/j.jagp.2025.09.020_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaneurol.2021.2161","article-title":"Global prevalence of young-onset dementia","volume":"78","author":"Hendriks","year":"2021","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.jagp.2025.09.020_bib0039","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","article-title":"The national alzheimer's coordinating center (NACC) database: the uniform data set","volume":"21","author":"Beekly","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"8","key":"10.1016\/j.jagp.2025.09.020_bib0040","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archneur.65.8.1091","article-title":"Staging dementia using clinical dementia rating scale sum of boxes scores","volume":"65","author":"O'Bryant","year":"2008","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.jagp.2025.09.020_bib0041","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","article-title":"Measurement of functional activities in older adults in the community","volume":"37","author":"Pfeffer","year":"1982","journal-title":"J Gerontol"},{"issue":"1","key":"10.1016\/j.jagp.2025.09.020_bib0042","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17","author":"Yesavage","year":"1982","journal-title":"J Psychiatr Res"},{"issue":"2","key":"10.1016\/j.jagp.2025.09.020_bib0043","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/07317115.2020.1839992","article-title":"Performance of the geriatric depression scale-15 with older adults aged over 65 years: an updated review 2000-2019","volume":"44","author":"Park","year":"2021","journal-title":"Clin Gerontol"},{"issue":"1","key":"10.1016\/j.jagp.2025.09.020_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National institute on aging-alzheimer's association guidelines for the neuropathologic assessment of alzheimer's disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.jagp.2025.09.020_bib0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jalz.2015.07.492","article-title":"Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of alzheimer's disease","volume":"12","author":"Montine","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.jagp.2025.09.020_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.jagp.2025.09.020_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105864","article-title":"Emerging concepts in vascular dementia: a review","volume":"30","author":"Bir","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"10.1016\/j.jagp.2025.09.020_bib0048","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0035-1555115","article-title":"The impact of age on cognition","volume":"36","author":"Murman","year":"2015","journal-title":"Semin Hear"},{"issue":"1","key":"10.1016\/j.jagp.2025.09.020_bib0049","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1529100620920576","article-title":"Education and cognitive functioning across the life span","volume":"21","author":"L\u00f6vd\u00e9n","year":"2020","journal-title":"Psychol Sci Publ Int"},{"issue":"1","key":"10.1016\/j.jagp.2025.09.020_bib0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41398-017-0064-8","article-title":"Apolipoprotein-E (apoe) \u03b54 and cognitive decline over the adult life course","volume":"8","author":"Rawle","year":"2018","journal-title":"Transl Psychiatr"},{"issue":"1","key":"10.1016\/j.jagp.2025.09.020_bib0051","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Royal Stat Soc. Series B (Methodol)."},{"key":"10.1016\/j.jagp.2025.09.020_bib0052","series-title":"A language and environment for statistical computing (Version 4.4.1)","year":"2024"},{"key":"10.1016\/j.jagp.2025.09.020_bib0053","unstructured":"Posit Team. RStudio: Integrated development environment for R. Posit Software Web site. http:\/\/www.posit.co\/. Accessed July 15, 2025."},{"issue":"7","key":"10.1016\/j.jagp.2025.09.020_bib0054","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jamda.2019.03.037","article-title":"Antidepressant and risk of dementia: confounding by indication","volume":"20","author":"Liew","year":"2019","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jagp.2025.09.020_bib0055","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.trci.2019.06.005","article-title":"Disease severity and minimal clinically important differences in clinical outcome assessments for alzheimer's disease clinical trials","volume":"5","author":"Andrews","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"issue":"4","key":"10.1016\/j.jagp.2025.09.020_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2024.105482","article-title":"Prolonged use of antidepressants among older people residing in long-term care facilities","volume":"26","author":"Hughes","year":"2025","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jagp.2025.09.020_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2025.04.037","article-title":"Antidepressant trial duration versus duration of real-world use: a systematic analysis","author":"Ward","year":"2025","journal-title":"Am J Med"},{"key":"10.1016\/j.jagp.2025.09.020_bib0058","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75204-8","article-title":"Critical assessment of anti-amyloid-\u03b2 monoclonal antibodies effects in alzheimer\u2019s disease: a systematic review and meta-analysis highlighting target engagement and clinical meaningfulness","volume":"14","author":"Avgerinos","year":"2024","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.jagp.2025.09.020_bib0059","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/1533317511432734","article-title":"Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia","volume":"26","author":"Lau","year":"2011","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"8","key":"10.1016\/j.jagp.2025.09.020_bib0060","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00702-022-02521-5","article-title":"The enigma of vascular depression in old age: a critical update","volume":"129","author":"Jellinger","year":"2022","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"10.1016\/j.jagp.2025.09.020_bib0061","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1073\/pnas.97.1.325","article-title":"Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone","volume":"97","author":"Wong","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.jagp.2025.09.020_bib0062","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/npp.2012.191","article-title":"Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets","volume":"38","author":"Cattaneo","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.jagp.2025.09.020_bib0063","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jagp.2025.09.020_bib0064","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.03.019","article-title":"The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery","volume":"45","author":"Dahl","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jagp.2025.09.020_bib0065","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.euroneuro.2021.09.006","article-title":"Depression and inflammation: correlation between changes in inflammatory markers with antidepressant response and long-term prognosis","volume":"54","author":"Kofod","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.jagp.2025.09.020_bib0066","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/01.psy.0000160467.78373.d8","article-title":"Depressive symptoms are associated with increased systemic vascular resistance to stress","volume":"67","author":"Matthews","year":"2005","journal-title":"Psychosom Med"},{"issue":"4","key":"10.1016\/j.jagp.2025.09.020_bib0067","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.61.4.369","article-title":"Relationship between atherosclerosis and late-life depression: the rotterdam study","volume":"61","author":"Tiemeier","year":"2004","journal-title":"Arch Gener Psychiatr"},{"issue":"7","key":"10.1016\/j.jagp.2025.09.020_bib0068","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/gps.2572","article-title":"Hypertension is a potential risk factor for vascular dementia: systematic review","volume":"26","author":"Sharp","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"10.1016\/j.jagp.2025.09.020_bib0069","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archinternmed.2010.393","article-title":"Heavy smoking in midlife and long-term risk of alzheimer disease and vascular dementia","volume":"171","author":"Rusanen","year":"2011","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.jagp.2025.09.020_bib0070","article-title":"Selective serotonin reuptake inhibitors and associated bleeding risks: a narrative and clinical review","volume":"10","author":"Edinoff","year":"2022","journal-title":"Health Psychol Res"},{"issue":"6","key":"10.1016\/j.jagp.2025.09.020_bib0071","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ajg.2014.82","article-title":"Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis","volume":"109","author":"Anglin","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"18","key":"10.1016\/j.jagp.2025.09.020_bib0072","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1212\/WNL.0b013e318271f848","article-title":"Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis","volume":"79","author":"Hackam","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jagp.2025.09.020_bib0073","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3233\/JAD-170387","article-title":"Serotonin selective reuptake inhibitor treatment improves cognition and grey matter atrophy but not amyloid burden during two-year follow-up in mild cognitive impairment and alzheimer's disease patients with depressive symptoms","volume":"65","author":"Brendel","year":"2018","journal-title":"J Alzheimers Dis"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748125004889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748125004889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:43:00Z","timestamp":1773862980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748125004889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1064748125004889"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2025.09.020","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship Between SSRI Exposure During Later Life and Clinical and Neuropathological Correlates of Dementia","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2025.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}